Earnings History Data for Anebulo Pharmaceuticals, Inc. (ANEB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals Inc. is a clinical-stage biotechnology company. It involved in developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The company's product candidate includes ANEB-001. Anebulo Pharmaceuticals Inc. is based in Texas, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25-09-2024 | PM | ANEB | Anebulo Pharmaceuticals, Inc. | 57.57 | -0.05 | 0.00 | -0.10 | Anebulo Pharmaceuticals GAAP EPS of -$0.05 [9/26/2024 6:30 AM] |
1.84 | -0.01 (-0.54%) |
1.89 | 0.04 (2.16%) |
1.62 - 3.61 | 2,511 | 20,000 | 260 | ||
| 13-02-2024 | AH | ANEB | Anebulo Pharmaceuticals | 64.00 | -0.11 | -0.11 | 0.00 | Anebulo Pharmaceuticals GAAP EPS of -$0.11 misses by $0.01 [2/13/2024 5:09 PM] |
2.69 | 0.11 (4.26%) |
0.0 | 0.0 (0.00%) |
1.62 - 4.05 | 2,352 | 10,000 | 0 | ||
| 14-11-2023 | PM | ANEB | Anebulo Pharmaceuticals | 55.00 | -0.10 | -0.11 | 0.00 | Anebulo Pharmaceuticals GAAP EPS of -$0.10 beats by $0.02 [11/15/2023 8:49 AM] |
2.23 | 0.11 (5.19%) |
0.0 | 0.0 (0.00%) |
1.62 - 4.05 | 3,175 | 10,000 | 0 | ||
| 20-09-2023 | AH | ANEB | Anebulo Pharmaceuticals | 84.00 | -0.10 | -0.10 | 0.00 | Anebulo Pharmaceuticals GAAP EPS of -$0.10 beats by $0.01 [9/20/2023 4:31 PM] |
3.48 | 0.0 (0.00%) |
3.48 | 0.0 (0.00%) |
1.77 - 4.05 | 8,034 | 10,000 | 578 | ||
| 10-11-2022 | PM | ANEB | Anebulo Pharmaceuticals, Inc. | 65.36 | -0.11 | 0.00 | -0.07 | Anebulo Pharmaceuticals GAAP EPS of -$0.11 misses by $0.01 [11/10/2022 9:46 AM] |
2.74 | 0.26 (10.48%) |
0.0 | 0.0 (0.00%) |
1.77 - 7.89 | 15,861 | 0 | 0 | ||